Purchase Order 75N92022P00263
Award Date
8/11/22
Potential Completion Date
8/10/23
Potential Value
$82K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Archerdx LLC
Ultimate Awardee
Invitae Corporation
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boulder, CO 80301, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order for $96,204.00 was awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Archerdx LLC, a subsidiary of Invitae Corporation. The contract supports research on the "Inflammation and Cardiac Disease Association with Clonal Hematopoiesis" and does not have a set-aside designation. Archerdx, a genomic analysis company, has previously received awards from NIH and the Defense Health...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order to Archerdx LLC, a subsidiary of Invitae Corporation, for ARCHERDX VARIANTPLEX KITS for myeloid research. The potential value of the contract is $116,070.00. Archerdx LLC is a genomic analysis company that has previously provided DNA sequencing reagents, variant detection kits, and related products to the NIH, including the NHLBI and NIAID,...
Archerdx LLC, a subsidiary of Invitae Corporation, has been awarded a firm fixed price purchase order by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH). Under this contract, Archerdx will provide the NHLBI with custom DNA sequencing library reagents to detect and quantify the frequency of acute myeloid leukemia-associated mutations in patient samples. The contract has a period of performance from September 12, 2023 through November 11, 2023...
This is a firm fixed price contract awarded by the Defense Health Agency (DHA) to Archerdx LLC, a subsidiary of Invitae Corporation, for $75,000.00. The contract requires the contractor to provide lab supplies and assays used to perform clinical diagnosis of medical conditions. This award is not associated with a set-aside program. Through past federal contract awards, Archerdx has provided DNA sequencing library reagents, variant detection kits, and related products to support research...
This federal contract award, valued at $75,000.00, was issued by the Defense Health Agency (DHA) to Archerdx LLC, a subsidiary of Invitae Corporation. The contract is for the provision of lab supplies and assays, medical, surgical instruments, equipment, and supplies. The contract type is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing structure. The award is not associated with a set-aside program. Archerdx LLC has previously received federal contract awards...
The National Institutes of Health National Human Genome Research Institute awarded a $25,000 firm fixed price purchase order to Invitae Corporation of San Francisco, California for clinical testing services in support of NIH clinical investigators. Under the contract, which runs from September 1, 2023 through August 31, 2024, Invitae will provide clinical testing for the NHGRI Clinical Investigators program. No subcontractors or set aside designations were identified. The contract was awarded...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $81,254.25 and a period of performance ending on August 18, 2017. It does not have a set-aside designation. The contract provides for Illumina to deliver a range of genomic sequencing systems, reagents, consumables, and support services to the NHLBI. This includes Illumina's...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, awarded a $999,999.00 firm fixed price purchase order to Illumina, Inc. to provide a NovaSeq X Plus sequencing system. This award is based on a September 2023 solicitation from the National Heart Lung and Blood Institute seeking a high-throughput DNA sequencing platform to support genomic research. The contract has no set-aside designation and a...
This firm-fixed-price purchase order for $114,787.00 was awarded by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) to provide the ARCHERDx VariantPlex System. The award has no set-aside designation and is expected to be completed by June 23, 2025. IDT is a major provider of specialized nucleic acid products and services to federal agencies. The company frequently supports pandemic...